Role of Dickkopf-1, an Antagonist of the Wnt/β-Catenin Signaling Pathway, in Estrogen-Induced Neuroprotection and Attenuation of Tau Phosphorylation

17β-Estradiol (E2) has been implicated to be neuroprotective in a variety of neurodegenerative disorders, although the mechanism remains poorly understood. The current study sheds light on this issue by demonstrating that low physiological levels of E2 protects the hippocampus CA1 against global cerebral ischemia by preventing elevation of dickkopf-1 (Dkk1), an antagonist of the Wnt/β-catenin signaling pathway, which is a principal mediator of neurodegeneration in cerebral ischemia and Alzheimer's disease. E2 inhibition of Dkk1 elevation correlated with a reduction of phospho-β-catenin and elevation of nuclear β-catenin levels, as well as enhancement of Wnt-3, suggesting E2 activation of the Wnt/β-catenin signaling pathway. In agreement, the β-catenin downstream prosurvival factor, survivin, was induced by E2 at 24 and 48 h after cerebral ischemia, an effect observed only in surviving neurons because degenerating neurons lacked survivin expression. E2 suppression of Dkk1 elevation was found to be caused by attenuation of upstream c-Jun N-terminal protein kinase (JNK)/c-Jun signaling, as E2 attenuation of JNK/c-Jun activation and a JNK inhibitor significantly blocked Dkk1 induction. Tau hyperphosphorylation has been implicated to have a prodeath role in Alzheimer's disease and cerebral ischemia, and E2 attenuates tau hyperphosphorylation. Our study demonstrates that tau hyperphosphorylation is strongly induced after global cerebral ischemia, and that E2 inhibits tau hyperphosphorylation by suppressing activation of the JNK/c-Jun/Dkk1 signaling pathway. Finally, exogenous Dkk1 replacement via intracerebroventricular administration completely reversed E2-induced neuroprotection, nuclear β-catenin induction, and phospho-tau attenuation, further suggesting that E2 inhibition of Dkk1 is a critical mechanism underlying its neuroprotective and phospho-tau regulatory effects after cerebral ischemia.

[1]  D. Brann,et al.  Neurotrophic and neuroprotective actions of estrogen: Basic mechanisms and clinical implications , 2007, Steroids.

[2]  Andrea Caricasole,et al.  Induction of the Wnt Inhibitor, Dickkopf‐1, Is Associated with Neurodegeneration Related to Temporal Lobe Epilepsy , 2007, Epilepsia.

[3]  T. Jover-Mengual,et al.  MAPK signaling is critical to estradiol protection of CA1 neurons in global ischemia. , 2007, Endocrinology.

[4]  Quan-guang Zhang,et al.  Critical role of PTEN in the coupling between PI3K/Akt and JNK1/2 signaling in ischemic brain injury , 2007, FEBS letters.

[5]  Quan-guang Zhang,et al.  Antioxidant N-acetylcysteine inhibits the activation of JNK3 mediated by the GluR6–PSD95–MLK3 signaling module during cerebral ischemia in rat hippocampus , 2006, Neuroscience Letters.

[6]  G. Terstappen,et al.  Inhibition of Wnt signaling, modulation of Tau phosphorylation and induction of neuronal cell death by DKK1 , 2006, Neurobiology of Disease.

[7]  D. Rodriguez,et al.  Casein kinase 2 (CK2) increases survivin expression via enhanced β-catenin–T cell factor/lymphoid enhancer binding factor-dependent transcription , 2006, Proceedings of the National Academy of Sciences.

[8]  Tian-Le Xu,et al.  Akt inhibits MLK3/JNK3 signaling by inactivating Rac1: a protective mechanism against ischemic brain injury , 2006, Journal of neurochemistry.

[9]  R. Berry,et al.  Formation of Phospho-SAPK/JNK Granules in the Hippocampus Is an Early Event in Alzheimer Disease , 2006, Journal of neuropathology and experimental neurology.

[10]  V. W. Henderson,et al.  Estrogen-containing hormone therapy and Alzheimer’s disease risk: Understanding discrepant inferences from observational and experimental research , 2006, Neuroscience.

[11]  J. Fangusaro,et al.  Essential Role for Survivin in Early Brain Development , 2005, The Journal of Neuroscience.

[12]  J. Simpkins,et al.  Role of Nonfeminizing Estrogens in Brain Protection from Cerebral Ischemia: An Animal Model of Alzheimer's Disease Neuropathology , 2005, Annals of the New York Academy of Sciences.

[13]  J. Ávila,et al.  Estradiol Prevents Neural Tau Hyperphosphorylation Characteristic of Alzheimer's Disease , 2005, Annals of the New York Academy of Sciences.

[14]  C. Nguyên,et al.  Differential roles for the coactivators CBP and p300 on TCF/β-catenin-mediated survivin gene expression , 2005, Oncogene.

[15]  P. Sandercock,et al.  Influence of Gender on Baseline Features and Clinical Outcomes among 17,370 Patients with Confirmed Ischaemic Stroke in the International Stroke Trial , 2005, Neuroepidemiology.

[16]  G. Gaviraghi,et al.  Induction of Dickkopf-1, a Negative Modulator of the Wnt Pathway, Is Required for the Development of Ischemic Neuronal Death , 2005, The Journal of Neuroscience.

[17]  I. Grundke‐Iqbal,et al.  Tau pathology in Alzheimer disease and other tauopathies. , 2005, Biochimica et biophysica acta.

[18]  S. Fukuda,et al.  Survivin regulates the p53 tumor suppressor gene family , 2004, Oncogene.

[19]  E. Aronica,et al.  Induction of Dickkopf-1, a Negative Modulator of the Wnt Pathway, Is Associated with Neuronal Degeneration in Alzheimer's Brain , 2004, The Journal of Neuroscience.

[20]  J. Simpkins,et al.  Transient Cerebral Ischemia Induces Aberrant Neuronal Cell Cycle Re-entry and Alzheimer's Disease-like Tauopathy in Female Rats* , 2004, Journal of Biological Chemistry.

[21]  M. Gomis,et al.  Sex Differences in First-Ever Acute Stroke , 2003, Stroke.

[22]  C. Wolfe,et al.  Sex Differences in the Clinical Presentation, Resource Use, and 3-Month Outcome of Acute Stroke in Europe: Data From a Multicenter Multinational Hospital-Based Registry , 2003, Stroke.

[23]  S. Chiou,et al.  Survivin - an anti-apoptosis protein: its biological roles and implications for cancer and beyond. , 2003, Medical science monitor : international medical journal of experimental and clinical research.

[24]  H. Carswell,et al.  Estrogen is Neuroprotective via an Apolipoprotein E—Dependent Mechanism in a Mouse Model of Global Ischemia , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[25]  U. Rüther,et al.  The Wnt antagonist Dickkopf‐1 is regulated by Bmp signaling and c‐Jun and modulates programmed cell death , 2002, The EMBO journal.

[26]  S. Estus,et al.  The JNK/c-Jun cascade and Alzheimer's disease , 2002, American journal of Alzheimer's disease and other dementias.

[27]  David W. Anderson,et al.  SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[28]  R. Traystman,et al.  Estrogen and Bcl-2: Gene Induction and Effect of Transgene in Experimental Stroke , 2001, The Journal of Neuroscience.

[29]  L. Barbeito,et al.  The molecular bases of Alzheimer's disease and other neurodegenerative disorders. , 2001, Archives of medical research.

[30]  H. J. Kim,et al.  An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7. , 2001, Biochemistry.

[31]  J. Morrison,et al.  Neuroendocrine Aging in the Female Rat: The Changing Relationship of Hypothalamic Gonadotropin-Releasing Hormone Neurons and N-Methyl-d-Aspartate Receptors* *Preliminary versions of this work were presented at the 28th and 29th Annual Meetings of the Society for Neuroscience (Abstracts 110.11 and 77 , 2000, Endocrinology.

[32]  Jian Wang,et al.  Dickkopf-1, an inhibitor of the Wnt signaling pathway, is induced by p53 , 2000, Oncogene.

[33]  B. Crain,et al.  17beta-estradiol reduces stroke injury in estrogen-deficient female animals. , 1999, Stroke.

[34]  R. Traystman,et al.  Estrogen-mediated neuroprotection after experimental stroke in male rats. , 1998, Stroke.

[35]  Y Q Zhang,et al.  Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat. , 1997, Journal of neurosurgery.

[36]  D. Altieri,et al.  A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma , 1997, Nature Medicine.

[37]  Y. Yoneda,et al.  Selective Potentiation of DNA Binding Activities of Both Activator Protein 1 and Cyclic AMP Response Element Binding Protein Through In Vivo Activation of N‐Methyl‐d‐Aspartate Receptor Complex in Mouse Brain , 1994, Journal of neurochemistry.

[38]  R. Nusse,et al.  Regional expression of the Wnt-3 gene in the developing mouse forebrain in relationship to diencephalic neuromeres , 1992, Mechanisms of Development.

[39]  A. Buchan,et al.  The four-vessel occlusion rat model: method for complete occlusion of vertebral arteries and control of collateral circulation. , 1988, Stroke.

[40]  J. Brierley,et al.  A New Model of Bilateral Hemispheric Ischemia in the Unanesthetized Rat , 1979, Stroke.

[41]  D. Brann,et al.  Tamoxifen neuroprotection in cerebral ischemia involves attenuation of kinase activation and superoxide production and potentiation of mitochondrial superoxide dismutase. , 2008, Endocrinology.

[42]  R. Zukin,et al.  Estrogen can act via estrogen receptor alpha and beta to protect hippocampal neurons against global ischemia-induced cell death. , 2005, Endocrinology.

[43]  R. Zukin,et al.  Estrogen Can Act via Estrogen Receptor and to Protect Hippocampal Neurons against Global Ischemia- Induced Cell Death , 2005 .

[44]  Joanne M. Smith,et al.  Stroke in the female: role of biological sex and estrogen. , 2004, ILAR journal.

[45]  M. Bennett,et al.  Estrogen protects against global ischemia-induced neuronal death and prevents activation of apoptotic signaling cascades in the hippocampal CA1. , 2002, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[46]  J. Morrison,et al.  Neuroendocrine aging in the female rat: the changing relationship of hypothalamic gonadotropin-releasing hormone neurons and N-methyl-D-aspartate receptors. , 2000, Endocrinology.